Seven Korean AI medical technology firms to connect with UAE healthcare leaders at ADNEC.
Abu Dhabi: Seven South Korean artificial intelligence (AI) healthcare companies will showcase their latest technologies to UAE healthcare professionals and industry leaders at Medical Korea 2026 in the UAE: Digital Health AI.
The event will take place on Thursday, October 22, 2026, from 9.30am to 5.30pm at Capital Suite 3, ADNEC, Abu Dhabi.
Held alongside the Abu Dhabi Future Health Summit (ADFHS), the event is co-hosted by the Embassy of the Republic of Korea to the UAE and the Department of Health – Abu Dhabi (DoH), and organised by the Korea Health Industry Development Institute (KHIDI UAE).
The event will bring together UAE healthcare providers, investors and policymakers with Korean companies offering AI-powered healthcare solutions, creating opportunities for collaboration and supporting the UAE’s push towards greater use of artificial intelligence in healthcare.
Participating companies
Together, the seven companies offer AI-powered solutions covering different stages of the healthcare journey, from screening and diagnosis to patient monitoring, chronic disease management and clinical workflows.
- ARPI Inc. – ECG Buddy uses AI to analyse electrocardiograms, assess heart rhythms and identify the risk of critical cardiac conditions.
- Kakao Healthcare – PASTA uses AI-powered health data analysis to provide personalised support for managing diabetes, obesity and cardiometabolic health.
- Lunit – Lunit INSIGHT applies AI to medical imaging to support the early detection of lung and breast cancer and improve the efficiency of screening.
- Puzzle AI – Puzzle Gen combines AI-based speech recognition with a medical large language model (LLM) to automate clinical documentation and reduce administrative work for healthcare professionals.
- SEERS – mobiCARE and thynC combine wearable biosensors with AI technology to provide continuous ECG and real-time patient monitoring.
- VUNO – VUNO Med-DeepCARS uses AI to analyse patients’ vital signs and predict the risk of cardiac arrest within 24 hours, helping clinicians intervene earlier.
- Waycen – WAYMED ENDO analyses endoscopic images in real time, helping detect lesions and classify polyps during gastric and colorectal screening.
Following the company presentations, one-on-one business meetings will be held in the afternoon, giving hospitals, distributors and investors an opportunity to discuss potential partnerships, pilot projects and ways to integrate AI technologies into existing healthcare systems.
Healthcare professionals and other industry stakeholders are invited to attend, with the full programme available in the official event leaflet.
